PR97566

SINGAPORE, Sept. 1, 2022 /PRNewswire=KYODO JBN/ --

- Chris Lee aims to transform healthcare fundraising through VentureBlick's

fundraising platform and professional community

Chris Lee, one of the most experienced healthcare executives having held senior

positions including president of Medtronic Asia Pacific and head of Bayer

Healthcare Asia Pacific, today announced his new role as the founder and CEO of

VentureBlick, a platform aiming to transform healthcare fundraising by matching

healthcare startups with medical investors. Unlike traditional investors,

medical investors who join the platform, namely physicians, clinicians,

hospital administrators,and healthcare industry professionals with deep domain

expertise and user experience, will provide unparalleled value to startups –

not just as their investors, but also as their advisors and future customers.

As an early-stage startup aiming for an IPO, VentureBlick is dedicated to

helping early-stage healthcare startups get funding, product validation, and

market insights from medical investors – their ultimate customers – through its

fundraising platform and professional community. In turn, medical investors get

the chance to play an active role in developing the healthcare ecosystem and

invest in the latest innovations in healthcare – an area they are most familiar

with.

Healthcare startups face unique challenges such as long product development

time and high barriers to market access due to quality, regulatory, and

clinical requirements. These are in addition to two critical success factors

faced by every startup founder: securing funding without losing focus on their

product and validating if their product is what customers really want.

VentureBlick's platform will allow medical investors to systematically

evaluate, advise and invest in healthcare startups. Once the startup idea is

endorsed by a certain level of medical investors, it will be open to other

accredited investors who might not have medical knowledge but are interested in

healthcare investment. Its unique fundraising mechanism will enable founders to

raise funds without worrying about losing control over their startup, giving

them peace of mind. The professional community will also give founders the

support they need to develop a product the market really needs. In addition,

VentureBlick will partner with a broader group of institutional investors,

helping them screen and de-risk startups with its unique model at the early

stage before the startups are ready to collaborate with VCs or PEs for

later-stage development.

Chris Lee said, "Healthcare startups deserve a more specialized and effective

support system because the ecosystem they operate in is very unique. How can we

help them get market insights and customer feedback earlier in their journey?

Is there a better way to motivate all stakeholders to work together and

accelerate innovation? This inspired me to create a platform where startups can

meet their future customers so they can nurture new innovations together. After

30 years in the healthcare industry, I see a huge unmet need here and hope

VentureBlick can help narrow the gap."

VentureBlick has a presence in Australia, Korea, Singapore, and the USA. It is

in the midst of establishing a presence in China by early next year. Its

fundraising platform is targeted to launch in early 2023, and healthcare

startups and medical professionals who are interested may pre-register their

interest at www.ventureblick.com . In addition, VentureBlick will launch its own

venture capital fund, the VB Healthcare Fund, to invest in promising healthcare

startups.

Lee has extensive experience across multiple healthcare sectors including

pharmaceuticals, medical devices, animal health, diagnostics, and consumer

healthcare. He has worked in more than 10 countries, holding senior regional

and country leadership roles at Merck (MSD), Bristol Myers Squibb, Bayer, and

most recently Medtronic. Lee is among few Asians appointed to Executive

Committee positions in both top pharmaceutical and medtech companies. He has a

strong track record across M&As, strategic partnerships, new market expansion,

and startup incubation.

Lee is an active advocate of inclusive leadership and workplace happiness. He

has won multiple management awards including Most Respected CEO from Great

Place to Work for three consecutive years (2020-2022) and Executive of the Year

2021 by Singapore Business Review.

About VentureBlick

VentureBlick aims to transform healthcare fundraising through its fundraising

platform and professional community. Its fundraising platform matches

early-stage healthcare startups with medical investors (physicians, clinicians,

and industry experts) – the startups' potential customers – who can validate

ideas, support, and fund, without diluting startup control. Its professional

community provides the most practical and specialized advisory service, network

opportunities, and need-based operational services to help the startups grow.

It is the only fundraising platform that helps healthcare startups get funding,

market insights, and customer endorsement, all in one go.

Follow us on LinkedIn or visit www.ventureblick.com 

VentureBlick Media Contact / Investor Relations Inquiries

Elliza Yusof

Elliza.yusof@ventureblick.com

+65 9108 3101

SOURCE: VentureBlick

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=428151

   Caption: Chris Lee, Founder & CEO, VentureBlick.